Announcements Trials

Browse Landscape

Sponsor

Conditions

Radiation Fibrosis Syndrome 2 Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pancreatic Adenocarcinoma 1 Inflammation 1 Fibrosis 1 Fallopian Tube Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Camurati-Engelmann Syndrome 1

Interventions

pembrolizumab 65 Nivolumab 56 Ipilimumab 34 Specimen Handling 23 Magnetic Resonance Spectroscopy 21 Cyclophosphamide 17 Biopsy 13 Radiosurgery 12 relatlimab 11 fludarabine 11 binimetinib 11 Opdualag 11 CTLA-4 Antigen 11 trametinib 10 fludarabine phosphate 8 dabrafenib 8 lifileucel 7 encorafenib 7 aldesleukin 7 atezolizumab 6 Interleukin-2 6 cemiplimab 5 X-Rays 5 Paclitaxel 5 Immunoglobulin G 5 Blood Specimen Collection 5 Taxes 4 Radiotherapy 4 Pemetrexed 4 Gemcitabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Melanoma × Losartan × 90 days × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡